Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 14/20 | 0.43 |
| ▸ | CTSC | P53634 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29375970 | 1.00 | MME (0.46) | MMEENPEPCTSCBACE1BACE2 | |
| SCHEMBL30906339 | 0.94 | MME (0.41) | MMECTSCBACE1 | |
| SCHEMBL30123289 | 0.90 | ENPEP (0.48) | ENPEP | |
| SCHEMBL30053678 | 0.88 | MME (0.50) | MMEENPEPCTSC | |
| SCHEMBL29973181 | 0.88 | BACE1 (0.48) | ENPEPBACE1 | |
| SCHEMBL2198060 | 0.87 | CASP3 (0.36) | ENPEPBACE1BACE2 | |
| SCHEMBL29371327 | 0.87 | MME (0.50) | MMEENPEP | |
| SCHEMBL30165201 | 0.87 | ENPEP (0.43) | ENPEPCTSCBACE1BACE2 | |
| SCHEMBL30011153 | 0.87 | MME (0.42) | MMEENPEPCTSC | |
| SCHEMBL31039950 | 0.86 | BACE1 (0.44) | MMECTSCBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11396533-B2 | Process for the manufacture of GLP-1 analogues | Fresenius Kabi Ipsum S.R.L. (IT) | 2022-07-26 | — | — | US | disclosed |
| US-20220041680-A1 | PROCESS FOR THE MANUFACTURE OF GLP-1 ANALOGUES | Fresenius Kabi Ipsum S.R.L. (IT) | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220041680-A1 | PROCESS FOR THE MANUFACTURE OF GLP-1 ANALOGUES | GLP1R, IAPP, VIP | MME 1189/4885ENPEP 262/4885CTSC 26/4885 |
| US-11396533-B2 | Process for the manufacture of GLP-1 analogues | GLP1R, IAPP, VIP | MME 1189/4885ENPEP 262/4885CTSC 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.